← Eichor
Condition: Gastroesophageal Junction Adenocarcinoma Siewert Ii Iii Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastroesophageal Junction Adenocarcinoma Siewert Ii Iii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocar
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06163729Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esopha
Phase N/A · 1 location(s) · P. Herzen Moscow Oncology Research Institute · NCT07441785
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.